European parliament adopts its position on the Critical Medicines Act, strengthening security of cancer care in Europe

 The European Parliament recently adopted first-reading of the Critical Medicines Act, expanding "collaborative procurement and solidarity mechanisms, explicitly acknowledging their relevance to specialized treatments, including in oncology."  Now entering interinstitutional negotiations, the Critical Medicines Act ensures that continuity of care for cancer patients will remain a key focus area for European Union health policy. 

To read more about the Critical Medicines Act, click here.